Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9049575rdf:typepubmed:Citationlld:pubmed
pubmed-article:9049575lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9049575lifeskim:mentionsumls-concept:C0007226lld:lifeskim
pubmed-article:9049575lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:9049575lifeskim:mentionsumls-concept:C1522318lld:lifeskim
pubmed-article:9049575lifeskim:mentionsumls-concept:C0143993lld:lifeskim
pubmed-article:9049575lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9049575lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:9049575lifeskim:mentionsumls-concept:C1521828lld:lifeskim
pubmed-article:9049575pubmed:issue5lld:pubmed
pubmed-article:9049575pubmed:dateCreated1997-5-29lld:pubmed
pubmed-article:9049575pubmed:abstractTextPharmacokinetics and haemodynamic effects of a total dose of 15 micrograms.kg-1 sufentanil, an opioid anaesthetic agent, were studied in patients undergoing aortocoronary bypass surgery at three infusion rates of 30 (group I), 5 (group II), and 2 (group III) micrograms.kg-1.min-1, respectively.lld:pubmed
pubmed-article:9049575pubmed:languageenglld:pubmed
pubmed-article:9049575pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9049575pubmed:citationSubsetIMlld:pubmed
pubmed-article:9049575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9049575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9049575pubmed:statusMEDLINElld:pubmed
pubmed-article:9049575pubmed:issn0031-6970lld:pubmed
pubmed-article:9049575pubmed:authorpubmed-author:JohnsonWWlld:pubmed
pubmed-article:9049575pubmed:authorpubmed-author:CooneyGGlld:pubmed
pubmed-article:9049575pubmed:authorpubmed-author:TzengT BTBlld:pubmed
pubmed-article:9049575pubmed:authorpubmed-author:BorensteinMMlld:pubmed
pubmed-article:9049575pubmed:authorpubmed-author:ShupakRRlld:pubmed
pubmed-article:9049575pubmed:authorpubmed-author:BarnetteRRlld:pubmed
pubmed-article:9049575pubmed:issnTypePrintlld:pubmed
pubmed-article:9049575pubmed:volume51lld:pubmed
pubmed-article:9049575pubmed:ownerNLMlld:pubmed
pubmed-article:9049575pubmed:authorsCompleteYlld:pubmed
pubmed-article:9049575pubmed:pagination359-66lld:pubmed
pubmed-article:9049575pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:meshHeadingpubmed-meshheading:9049575-...lld:pubmed
pubmed-article:9049575pubmed:year1997lld:pubmed
pubmed-article:9049575pubmed:articleTitleCardiovascular effects of different infusion rates of sufentanil in patients undergoing coronary surgery.lld:pubmed
pubmed-article:9049575pubmed:affiliationSchool of Pharmacy, Temple University, Philadelphia, PA 19140, USA.lld:pubmed
pubmed-article:9049575pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9049575pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9049575pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:9049575pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed